Cargando…

Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults

Detalles Bibliográficos
Autores principales: Chen, Jun-Rong, Mai, Lei, Sun, Jia-Chen, Peng, Xiang, Zhang, Min, Zhi, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373931/
https://www.ncbi.nlm.nih.gov/pubmed/35975242
http://dx.doi.org/10.1093/gastro/goac032
_version_ 1784767690522492928
author Chen, Jun-Rong
Mai, Lei
Sun, Jia-Chen
Peng, Xiang
Zhang, Min
Zhi, Min
author_facet Chen, Jun-Rong
Mai, Lei
Sun, Jia-Chen
Peng, Xiang
Zhang, Min
Zhi, Min
author_sort Chen, Jun-Rong
collection PubMed
description
format Online
Article
Text
id pubmed-9373931
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93739312022-08-15 Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults Chen, Jun-Rong Mai, Lei Sun, Jia-Chen Peng, Xiang Zhang, Min Zhi, Min Gastroenterol Rep (Oxf) Brief Report Oxford University Press 2022-08-12 /pmc/articles/PMC9373931/ /pubmed/35975242 http://dx.doi.org/10.1093/gastro/goac032 Text en © The Author(s) 2022. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Chen, Jun-Rong
Mai, Lei
Sun, Jia-Chen
Peng, Xiang
Zhang, Min
Zhi, Min
Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
title Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
title_full Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
title_fullStr Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
title_full_unstemmed Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
title_short Efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
title_sort efficacy and safety of low-dose thalidomide combined with mesalazine in the treatment of refractory ulcerative colitis in adults
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373931/
https://www.ncbi.nlm.nih.gov/pubmed/35975242
http://dx.doi.org/10.1093/gastro/goac032
work_keys_str_mv AT chenjunrong efficacyandsafetyoflowdosethalidomidecombinedwithmesalazineinthetreatmentofrefractoryulcerativecolitisinadults
AT mailei efficacyandsafetyoflowdosethalidomidecombinedwithmesalazineinthetreatmentofrefractoryulcerativecolitisinadults
AT sunjiachen efficacyandsafetyoflowdosethalidomidecombinedwithmesalazineinthetreatmentofrefractoryulcerativecolitisinadults
AT pengxiang efficacyandsafetyoflowdosethalidomidecombinedwithmesalazineinthetreatmentofrefractoryulcerativecolitisinadults
AT zhangmin efficacyandsafetyoflowdosethalidomidecombinedwithmesalazineinthetreatmentofrefractoryulcerativecolitisinadults
AT zhimin efficacyandsafetyoflowdosethalidomidecombinedwithmesalazineinthetreatmentofrefractoryulcerativecolitisinadults